Digest Network Come funziona
Network
/
Società
Th
Non verificato

The NIMML Institute

Di cosa scriviamo

BiotecnologiaFarmaceuticaMedicina - VarieSaluteVolontariato/Solidarietà/Non profit

3 comunicati stampa

Guarda tutti i comunicati
21/04/2025
Volontariato/Solidarietà/Non profit
Industria
Biotecnologia
Farmaceutica
Salute
HIV, AIDS e malattie autoimmuni
Tecnica
Medicina - Varie
The NIMML Institute and NImmune Biopharma Showcase How the TITAN-X A.I. Platform has Accelerated Therapeutic Development in the Annual Review of Biomedical Data Science
Fonte
The NIMML Institute
Emittente
Business Wire
1.00
0
10/04/2025
Volontariato/Solidarietà/Non profit
Fiere
Eventi
Biotecnologia
Sanità
Salute
Farmaceutica
Medicina - Varie
NIMML Institute to Present Novel Clinical and Translational Data of Omilancor in Ulcerative Colitis Patients at Digestive Disease Week 2025
Fonte
The NIMML Institute
Emittente
Business Wire
1.00
0
13/01/2025
Volontariato/Solidarietà/Non profit
Industria
Salute
HIV, AIDS e malattie autoimmuni
Medicina - Varie
Scienza
Farmaceutica
Biotecnologia
The NIMML Institute and NImmune Biopharma Announce Publication of Positive First-in-Human Data of NIM-1324, a Phase 2 Candidate for Systemic Lupus Erythematosus, in Clinical and Translational Science
Fonte
The NIMML Institute
Emittente
Business Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0